Ghafoor A - Search Results

1

Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.

Hassan R, Butler M, O'Cearbhaill RE, Oh DY, Johnson M, Zikaras K, Smalley M, Ross M, Tanyi JL, Ghafoor A, Shah NN, Saboury B, Cao L, Quintás-Cardama A, Hong D. Hassan R, et al. Among authors: ghafoor a. Nat Med. 2023 Aug;29(8):2099-2109. doi: 10.1038/s41591-023-02452-y. Epub 2023 Jul 27. Nat Med. 2023. PMID: 37501016 Free PMC article. Clinical Trial.

2

Targeting mesothelin in ovarian cancer.

Ghafoor A, Thomas A, Hassan R. Ghafoor A, et al. Oncotarget. 2018 Nov 16;9(90):36050-36051. doi: 10.18632/oncotarget.26350. eCollection 2018 Nov 16. Oncotarget. 2018. PMID: 30546824 Free PMC article. No abstract available.

3

Orbital metastases from malignant mesothelioma.

Mian I, Padiernos E, Hassan R, Ghafoor A. Mian I, et al. Among authors: ghafoor a. Lancet Oncol. 2020 Feb;21(2):e117. doi: 10.1016/S1470-2045(19)30822-8. Lancet Oncol. 2020. PMID: 32007197 Free PMC article. No abstract available.

4

Intracardiac Involvement by Primary Malignant Mesothelioma: A Report of Two Cases.

Kabbash MS, Edmund J, Ghafoor A, Hassan R, Rosing D, Thomas A. Kabbash MS, et al. Among authors: ghafoor a. J Thorac Oncol. 2020 Feb;15(2):e25-e27. doi: 10.1016/j.jtho.2019.08.2504. J Thorac Oncol. 2020. PMID: 32127186 Free article. No abstract available.

5

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models.

Jiang Q, Ghafoor A, Mian I, Rathkey D, Thomas A, Alewine C, Sengupta M, Ahlman MA, Zhang J, Morrow B, Steinberg SM, Pastan I, Hassan R. Jiang Q, et al. Among authors: ghafoor a. Sci Transl Med. 2020 Jul 1;12(550):eaaz7252. doi: 10.1126/scitranslmed.aaz7252. Sci Transl Med. 2020. PMID: 32611684 Free PMC article.

6

Malignant mesothelioma: Advances in immune checkpoint inhibitor and mesothelin-targeted therapies.

Hu ZI, Ghafoor A, Sengupta M, Hassan R. Hu ZI, et al. Among authors: ghafoor a. Cancer. 2021 Apr 1;127(7):1010-1020. doi: 10.1002/cncr.33433. Epub 2021 Feb 23. Cancer. 2021. PMID: 33620732 Free PMC article. Review.

7

Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.

Hu ZI, Miettinen M, Quezado M, Lebensohn AP, Aldape K, Agra M, Wagner C, Mallory Y, Hassan R, Ghafoor A. Hu ZI, et al. Among authors: ghafoor a. J Thorac Oncol. 2022 Mar;17(3):461-466. doi: 10.1016/j.jtho.2021.08.765. Epub 2021 Oct 8. J Thorac Oncol. 2022. PMID: 34628055 Free PMC article.

8

Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene.

Ghafoor A, Mian I, Wagner C, Mallory Y, Agra MG, Morrow B, Wei JS, Khan J, Thomas A, Sengupta M, Steinberg SM, Hassan R. Ghafoor A, et al. JTO Clin Res Rep. 2021 Sep 17;2(10):100231. doi: 10.1016/j.jtocrr.2021.100231. eCollection 2021 Oct. JTO Clin Res Rep. 2021. PMID: 34661178 Free PMC article.

9

Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy.

Ghafoor A, Hassan R. Ghafoor A, et al. J Thorac Oncol. 2022 Jul;17(7):862-864. doi: 10.1016/j.jtho.2022.05.005. J Thorac Oncol. 2022. PMID: 35750452 Free article. No abstract available.

10

Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome.

Lebensohn A, Ghafoor A, Bloomquist L, Royer MC, Castelo-Soccio L, Karacki K, Hathaway O, Maglo T, Wagner C, Agra MG, Blakely AM, Schrump DS, Hassan R, Cowen EW. Lebensohn A, et al. Among authors: ghafoor a. JAMA Dermatol. 2024 May 17:e241804. doi: 10.1001/jamadermatol.2024.1804. Online ahead of print. JAMA Dermatol. 2024. PMID: 38759225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page